S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
DIS   146.38 (-0.93%)
S&P 500   3,168.80 (+0.01%)
DOW   28,135.38 (+0.01%)
QQQ   207.19 (+0.33%)
AAPL   275.15 (+1.36%)
FB   194.11 (-1.34%)
MSFT   154.53 (+0.84%)
GOOGL   1,346.87 (-0.12%)
AMZN   1,760.94 (+0.03%)
NVDA   223.99 (-0.04%)
MU   51.20 (+0.45%)
BABA   204.91 (+0.20%)
GE   11.34 (-0.87%)
TSLA   358.39 (-0.36%)
T   38.26 (-0.23%)
AMD   41.15 (-3.38%)
F   9.23 (-0.97%)
NFLX   298.50 (+0.02%)
BAC   34.44 (-0.69%)
DIS   146.38 (-0.93%)
Log in

NYSE:AVNS - Avanos Medical Stock Price, Forecast & News

$32.48
+0.27 (+0.84 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$31.87
Now: $32.48
$32.59
50-Day Range
$32.07
MA: $36.43
$47.14
52-Week Range
$31.29
Now: $32.48
$53.45
Volume321,684 shs
Average Volume336,404 shs
Market Capitalization$1.56 billion
P/E Ratio39.61
Dividend YieldN/A
Beta1.46
Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-428-2667

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$652.30 million
Cash Flow$1.50 per share
Book Value$27.35 per share

Profitability

Net Income$57.50 million

Miscellaneous

Employees4,700
Market Cap$1.56 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive AVNS News and Ratings via Email

Sign-up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.


Avanos Medical (NYSE:AVNS) Frequently Asked Questions

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

How were Avanos Medical's earnings last quarter?

Avanos Medical Inc (NYSE:AVNS) announced its quarterly earnings data on Tuesday, November, 5th. The company reported $0.30 EPS for the quarter, missing the Zacks' consensus estimate of $0.32 by $0.02. The firm earned $171.40 million during the quarter, compared to analyst estimates of $179.98 million. Avanos Medical had a negative net margin of 6.20% and a positive return on equity of 3.92%. Avanos Medical's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.37 EPS. View Avanos Medical's Earnings History.

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Avanos Medical.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided EPS guidance of $1.00-1.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.19. The company issued revenue guidance of +5-7% yr/yr to ~$685-698 million, compared to the consensus revenue estimate of $708.11 million.

What price target have analysts set for AVNS?

6 brokerages have issued 1 year target prices for Avanos Medical's stock. Their forecasts range from $35.00 to $65.00. On average, they anticipate Avanos Medical's stock price to reach $48.75 in the next year. This suggests a possible upside of 50.1% from the stock's current price. View Analyst Price Targets for Avanos Medical.

What is the consensus analysts' recommendation for Avanos Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

Has Avanos Medical been receiving favorable news coverage?

Press coverage about AVNS stock has been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Avanos Medical earned a coverage optimism score of 1.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Avanos Medical.

Who are some of Avanos Medical's key competitors?

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), Alibaba Group (BABA), Home Depot (HD), CVS Health (CVS), Honeywell International (HON), Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO), Johnson & Johnson (JNJ) and The Coca-Cola (KO).

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the folowing people:
  • Mr. Joseph F. Woody, CEO & Director (Age 53)
  • Mr. John W. Wesley, Sr. VP of Legal & Gov. Relations (Age 60)
  • Mr. John R. Tushar, Pres of Global Franchises (Age 57)
  • Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 53)
  • Mr. Warren J. MacHan, Sr. VP of Bus. Strategy & Interim CFO (Age 53)

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include Paradice Investment Management LLC (4.71%), State Street Corp (3.70%), Rice Hall James & Associates LLC (0.88%), Alberta Investment Management Corp (0.51%), Rhumbline Advisers (0.34%) and Confluence Investment Management LLC (0.29%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

Which institutional investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including Select Equity Group L.P., State Street Corp, SG Americas Securities LLC, Rice Hall James & Associates LLC, Barclays PLC, Keybank National Association OH, Gateway Investment Advisers LLC and Somerset Trust Co. View Insider Buying and Selling for Avanos Medical.

Which institutional investors are buying Avanos Medical stock?

AVNS stock was purchased by a variety of institutional investors in the last quarter, including Paradice Investment Management LLC, State of New Jersey Common Pension Fund D, California Public Employees Retirement System, Confluence Investment Management LLC, Alberta Investment Management Corp, Virginia Retirement Systems ET AL, State of Alaska Department of Revenue and Massachusetts Financial Services Co. MA. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $32.48.

How big of a company is Avanos Medical?

Avanos Medical has a market capitalization of $1.56 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

What is Avanos Medical's official website?

The official website for Avanos Medical is http://www.halyardhealth.com/.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]


MarketBeat Community Rating for Avanos Medical (NYSE AVNS)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about Avanos Medical and other stocks. Vote "Outperform" if you believe AVNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel